MARATTO

article · Zenodo (CERN European Organization for Nuclear Research)

HAEMOSTASIS AND LENS OPACITY: INVESTIGATING THE RELATIONSHIP BETWEEN HAEMOSTATIC PARAMETERS AND CATARACT FORMATION

2025Open accessImo State University

Abstract

Cataract is a leading cause of treatable or avoidable blindness worldwide, particularly in older adults. While traditionally considered an ocular pathology, emerging evidence indicates that systemic factors, including disturbances in haemostasis, may contribute to cataract formation. This review systematically examines 15 clinical studies investigating haemostatic parameters such as platelet count, prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen levels in relation to cataractogenesis. Key findings indicate that elevated mean platelet volume (MPV), shortened PT/aPTT, and increased plasma fibrinogen are associated with lens opacity. However, most studies are cross-sectional, heterogeneous in design, and vary in haemostatic measurement methods. Limitations include small sample sizes and potential confounding from systemic diseases. Understanding the interplay between coagulation, inflammation, oxidative stress, and ocular microcirculation may enhance early identification of patients at risk and inform preventive strategies for cataract formation. Keywords: Cataract, Haemostasis, Platelet count, Prothrombin time, Activated partial thromboplastin time, Fibrinogen, Coagulation

Research topics

  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Inflammatory Biomarkers in Disease Prognosis
  • Blood properties and coagulation

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.5281/zenodo.18085757

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.